Beijing Scitop Bio-tech Balans Gezondheid
Financiële gezondheid criteriumcontroles 6/6
Beijing Scitop Bio-tech has a total shareholder equity of CN¥1.8B and total debt of CN¥607.2K, which brings its debt-to-equity ratio to 0.03%. Its total assets and total liabilities are CN¥1.9B and CN¥86.0M respectively. Beijing Scitop Bio-tech's EBIT is CN¥63.5M making its interest coverage ratio -6.7. It has cash and short-term investments of CN¥398.3M.
Belangrijke informatie
0.03%
Verhouding schuld/eigen vermogen
CN¥607.15k
Schuld
| Rente dekkingsratio | -6.7x |
| Contant | CN¥398.33m |
| Aandelen | CN¥1.76b |
| Totaal verplichtingen | CN¥86.01m |
| Totaal activa | CN¥1.85b |
Recente financiële gezondheidsupdates
Geen updates
Recent updates
Beijing Scitop Bio-tech Co., Ltd.'s (SZSE:300858) Earnings Haven't Escaped The Attention Of Investors
Sep 27
Weak Statutory Earnings May Not Tell The Whole Story For Beijing Scitop Bio-tech (SZSE:300858)
Aug 27Beijing Scitop Bio-tech (SZSE:300858) Will Pay A Smaller Dividend Than Last Year
Jun 29Investor Optimism Abounds Beijing Scitop Bio-tech Co., Ltd. (SZSE:300858) But Growth Is Lacking
Apr 18Beijing Scitop Bio-tech (SZSE:300858) Is Reinvesting At Lower Rates Of Return
Mar 22Analyse van de financiële positie
Kortlopende schulden: 300858's short term assets (CN¥867.8M) exceed its short term liabilities (CN¥53.6M).
Langlopende schulden: 300858's short term assets (CN¥867.8M) exceed its long term liabilities (CN¥32.4M).
Schuld/ eigen vermogen geschiedenis en analyse
Schuldniveau: 300858 has more cash than its total debt.
Schuld verminderen: 300858's debt to equity ratio has reduced from 0.8% to 0.03% over the past 5 years.
Schuldendekking: 300858's debt is well covered by operating cash flow (22010.8%).
Rentedekking: 300858 earns more interest than it pays, so coverage of interest payments is not a concern.